Conditions: Schizophrenia
Keywords: Schizophrenia SM-13496 Latuda Lurasidone
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 489
Healthy volunteers: no

Brief summary:
Lurasidone HCl is a compound being developed for the treatment of schizophrenia. This clinical study is designed to test the hypothesis that lurasidone is more efficacious than placebo. The study will also evaluate the safety and tolerability of lurasidone as compared to placebo.

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None arm 4: None

Interventions: intervention 1: Lurasidone HCl
Intervention descriptions: intervention 1: Once daily

Protocol document: